Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Langer

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
Dermato-Endocrinology|September 30, 2017
Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with self-reported premenopausal hirsutism and/or oligo-amenorrheaF V Comim, C S Wippel, R M Copês, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
Cancers|February 10, 2024
Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical CarcinoidsPatrick Soldath, Daniel Bianchi, Beatrice Manfredini, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung CancerTine N Christensen, Seppo W Langer, Gitte Persson, et al.
Case Reports in Medicine|January 23, 2016
Cowden Syndrome and Concomitant Pulmonary Neuroendocrine Tumor: A Presentation of Two CasesSeppo W Langer, Lene Ringholm, Christine I Dali, et al.
Acta Oncologica (Stockholm, Sweden)|March 29, 2021
A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)Isak T Laenkholm, Seppo W Langer, Mikkel Andreassen, et al.
Frontiers in Immunology|December 29, 2022
Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancerHeidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 24, 2016
Head-to-Head Comparison of <sup>64</sup>Cu-DOTATATE and <sup>68</sup>Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine TumorsCamilla B Johnbeck, Ulrich Knigge, Annika Loft, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Correction: Christensen et al. Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. <i>Diagnostics</i> 2021, <i>11</i>, 279Tine N Christensen, Seppo W Langer, Gitte Persson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2018
A Competing Risk Model of First Failure Site after Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerLotte Nygård, Ivan R Vogelius, Barbara M Fischer, et al.
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
Dermato-Endocrinology|September 30, 2017
Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with self-reported premenopausal hirsutism and/or oligo-amenorrheaF V Comim, C S Wippel, R M Copês, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
Cancers|February 10, 2024
Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical CarcinoidsPatrick Soldath, Daniel Bianchi, Beatrice Manfredini, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung CancerTine N Christensen, Seppo W Langer, Gitte Persson, et al.
Case Reports in Medicine|January 23, 2016
Cowden Syndrome and Concomitant Pulmonary Neuroendocrine Tumor: A Presentation of Two CasesSeppo W Langer, Lene Ringholm, Christine I Dali, et al.
Acta Oncologica (Stockholm, Sweden)|March 29, 2021
A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)Isak T Laenkholm, Seppo W Langer, Mikkel Andreassen, et al.
Frontiers in Immunology|December 29, 2022
Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancerHeidi Ryssel, Kristian Egebjerg, Susanne Dam Nielsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 24, 2016
Head-to-Head Comparison of <sup>64</sup>Cu-DOTATATE and <sup>68</sup>Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine TumorsCamilla B Johnbeck, Ulrich Knigge, Annika Loft, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Correction: Christensen et al. Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. <i>Diagnostics</i> 2021, <i>11</i>, 279Tine N Christensen, Seppo W Langer, Gitte Persson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2018
A Competing Risk Model of First Failure Site after Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerLotte Nygård, Ivan R Vogelius, Barbara M Fischer, et al.
Pageof 20